Loading
Bayer Cropscience Stock: price and insider trades · India
IN·Mcap ₹161.1B
1 insider bought shares over the last 90 days, the latest by Bayer AG, filed 31 Jul 2026.
Bayer Cropscience: what insiders have been doing
Every trade that managers of Bayer Cropscience disclose to SEBI (PIT + SAST) is tracked on this page. 4 insiders have disclosed 5 filings since 26 October 2025.
The flow runs one way only: 1 insider bought (1 purchase) and nobody sold on the market. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The last purchase on record was published on 31 July 2026, which is 87 days ago. Half of the filings or more reach the SEBI (PIT + SAST) feed on the day of the trade. The shorter that gap, the sooner other investors can see what insiders have done.
Across the 1,985 companies tracked on its exchange, the median is 4 filings; at 5 filings, this issuer sits above that mark. Our records for Bayer Cropscience go back to 2026, with 1 purchase and no sales on the open market in total.
These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleBayer AG1 buy
Analyst consensus: bullish or bearish?
Analysts rate Bayer Cropscience Buy (bullish), based on 7 analysts. Average price target: ₹5,126.43.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 5,287 of 26,320 companies
66.9
score / 100
Value55
Quality79
FCF yld6.7%
Earn yld4.5%
EV/EBITDA15.8x
ROE24%
Gross mgn38%
Net mgn13%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹3,584.50
Analyst consensus
7 analystsBuy
₹4,450.00Target ₹5,126.43(+43%)₹5,780.00
Income statement
Revenue₹55B
Gross profit₹20.9B38% margin
EBITDA₹9.7B18% margin
Net income₹6.9B13.1% margin
Valuation
PER (trailing)22.0x
PER (forward)19.1x
P/Book5.4x
Beta0.22
Balance sheet & cash
Market cap₹161.1B
Total debt₹818M
Free Cash Flow₹10.1B
Debt / Equity3%
Profitability & ownership
ROE23.7%
ROA8.9%
% insiders71.7%
% institutions11.9%
Last declaration on 31 July 2026
Declarations5 total
5,354,030 shares--SEBI:ea17f415bcd1a880ebddabe2b5cacd6da375a50a
Canonical exit: 29 Oct 2026 (T+90)
5,354,030 shares-Inter-se TransferSEBI:db743c58467c82914b0d6f86c209a745b6174bf8
5,354,030 shares-Inter-se TransferSEBI:175770dced6fd2e462f1bf3dba705820a6270a29
5,354,030 shares@ ₹4,122.3013.29% mcap100.0% of flowEquityInter-se-TransferSEBI:f2ffe0a3a1186fa2b98dd0c35e55a2363d8fa982
5,354,030 shares@ ₹4,122.3013.29% mcap100.0% of flowEquityInter-se-TransferSEBI:189d60ef059be88679516c8b61cead713a4a53a0
5 of 5 declarations
About Bayer Cropscience
Bayer Cropscience is a company focused on agricultural solutions, providing crop protection products and seeds. It is part of the Bayer group, which is a global leader in health and agriculture.